Pediatric Dosing of Bactrim DS (Trimethoprim-Sulfamethoxazole)
Bactrim DS tablets are not typically used for pediatric dosing; instead, use weight-based dosing with regular-strength tablets or liquid formulation at 8-12 mg/kg/day of the trimethoprim component divided into 2 doses every 12 hours. 1
Standard Pediatric Dosing (Ages ≥2 months)
Bactrim is contraindicated in infants <2 months of age due to risk of kernicterus. 2, 1
For Most Infections (UTI, Otitis Media, Shigellosis)
- Dose: 8 mg/kg trimethoprim + 40 mg/kg sulfamethoxazole per day
- Frequency: Divided into 2 doses every 12 hours
- Duration: 10-14 days for UTI; 5 days for shigellosis 1
Weight-Based Tablet Dosing Guide
Using regular-strength Bactrim tablets (80 mg TMP/400 mg SMX):
- 10 kg (22 lbs): ½ tablet every 12 hours
- 20 kg (44 lbs): 1 tablet every 12 hours
- 30 kg (66 lbs): 1½ tablets every 12 hours
- 40 kg (88 lbs): 2 tablets every 12 hours OR 1 DS tablet every 12 hours 1
For Skin/Soft Tissue Infections (MRSA)
The IDSA guidelines recommend 8-12 mg/kg/day of trimethoprim component divided into either:
- 2 divided doses orally every 12 hours, OR
- 4 divided doses IV every 6 hours 3
This higher range (up to 12 mg/kg/day) is appropriate for more resistant organisms or severe infections.
Special Dosing Situations
Pneumocystis jirovecii Pneumonia (PCP)
Treatment: 15-20 mg/kg trimethoprim + 75-100 mg/kg sulfamethoxazole per day divided every 6 hours for 14-21 days 1
Prophylaxis: 150 mg/m² trimethoprim + 750 mg/m² sulfamethoxazole per day divided twice daily, given 3 consecutive days per week (maximum 320 mg TMP/1600 mg SMX daily) 4, 1
Renal Impairment
Dose adjustment is critical in renal dysfunction:
- CrCl >30 mL/min: Standard dosing
- CrCl 15-30 mL/min: 50% of standard dose
- CrCl <15 mL/min: Use not recommended 1
Why Not Bactrim DS for Young Children?
Bactrim DS tablets contain 160 mg trimethoprim/800 mg sulfamethoxazole—this is too large a dose increment for precise weight-based dosing in children. The regular-strength tablets (80 mg/400 mg) or liquid suspension allow for more accurate dose titration based on the child's weight. 1
For adolescents weighing ≥40 kg who can swallow large tablets, 1 DS tablet twice daily approximates the 8 mg/kg/day trimethoprim dosing and may be used. 1
Critical Safety Considerations
Monitor for serious adverse effects: Recent evidence shows TMP-SMX carries increased risk of:
- Skin reactions (2.5-fold higher risk of rash compared to other antibiotics) 5
- Stevens-Johnson syndrome and toxic epidermal necrolysis (particularly vs. azithromycin) 5
- Hematologic toxicity (pancytopenia, neutropenia, thrombocytopenia) 5
- Electrolyte disturbances (hyperkalaemia, hyponatraemia) 5
- Acute respiratory failure in adolescents/young adults (10-24 years)—FDA warning issued 6
Avoid in:
- Infants <2 months (kernicterus risk) 2, 1
- Pregnant women near term 2
- Nursing mothers of infants <2 months 2
- Severe renal impairment (CrCl <15 mL/min) 1
Dosing Optimization Based on Recent Evidence
Recent pharmacokinetic studies suggest that standard dosing of 8 mg/kg/day achieves adequate exposure for organisms with MIC ≤0.5 mg/L, but for more resistant pathogens (MIC 1 mg/L), doses of 12-15 mg/kg/day divided every 12 hours may be required in younger children to match adult exposures. 7, 8 This aligns with the IDSA guideline range of 8-12 mg/kg/day for MRSA infections. 3
For severe infections or resistant organisms, use the higher end of the dosing range (12 mg/kg/day trimethoprim component) rather than standard 8 mg/kg/day. 3, 7